Product Information
REFRESH OPTIVE EYE DROPS is a brand product labeled by Allergan, Inc., priced at $0.6591 per ML under NDC 00023324015. Its NADAC has been published 476 times since Nov 28, 2013.
Strength
5; 9 mg/mL; mg/mL
Manufacturer
Allergan, Inc.NDC
00023324015
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
CARBOXYMETHYLCELLULOSE SODIUM; GLYCERINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M018On Market Since
9/6/2006
Pharmacological Classes
Price Statistics
The NADAC for REFRESH OPTIVE EYE DROPS has been published 476 times since Nov 28, 2013, and over the history we have for it it has risen 15.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6591 per ML |
|---|---|
| All-time high | $0.7068 (Aug 12, 2026) |
| All-time low | $0.5703 (Nov 28, 2013) |
| 52-week high | $0.7068 |
| 52-week low | $0.6584 |
| Median price | $0.6206 |
| Average price | $0.6209 |
| Largest weekly change | +7.3% (Jun 17, 2026) |
| Weeks tracked | 476 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the carboxymethylcellulose sodium and glycerin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
carboxymethylcellulose sodium and glycerin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Non-Standardized Chemical Allergen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of REFRESH OPTIVE EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for REFRESH OPTIVE EYE DROPS, manufactured by Allergan, Inc., is $0.6591 per ML (NDC 00023324015), effective Sep 30, 2026.
How has the price of REFRESH OPTIVE EYE DROPS changed over time?
Over the history we have for it, the NADAC for REFRESH OPTIVE EYE DROPS has risen 15.6%. It has been tracked across 476 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for REFRESH OPTIVE EYE DROPS?
Since Nov 28, 2013, the NADAC for REFRESH OPTIVE EYE DROPS has ranged from a low of $0.5703 (Nov 28, 2013) to a high of $0.7068 (Aug 12, 2026), with a median of $0.6206 per ML.
Are there cheaper alternatives to REFRESH OPTIVE EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of REFRESH OPTIVE EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures REFRESH OPTIVE EYE DROPS?
REFRESH OPTIVE EYE DROPS (NDC 00023324015) is labeled by Allergan, Inc., and CMS classifies it as a brand product.